Remote Jobs at ProKidney Corp.
Find your next remote opportunity · 2 Open Positions
About
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research.
ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases potentially drive meaningful improvement in kidney function.
Late-stage CKD, Stage 3b - 4, is a key target for REACT™ therapy.
REACT™ has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program, which launched in January 2022.
For more information, visit www.prokidney.com.
Medical Writer – Contractor
ProKidney Corp.
Medical Writer preparing and finalizing regulatory documents for clinical development at ProKidney. Collaborating with cross-functional teams to ensure compliance with guidelines and consistency in messaging.
Senior Manager, Finance and Investor Relations
ProKidney Corp.
Lead FP&A, financial modeling, earnings prep, and investor relations for ProKidney, a kidney biotech. Support budgeting, forecasting, valuation, and capital-raising materials.
No more jobs available.